Clinical Trial Update: Ellipsys Vascular Access System Post Market Surveillance (PS) Study [NA]

View source ↗

Summary

Post-market surveillance study of the Ellipsys Vascular Access System completed, with results summarized by the sponsor. The study evaluated creation of arterio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Ellipsys Vascular Access System

Snippet

Sponsor: Medtronic Endovascular | Conditions: Renal Disease, End Stage, Kidney Disease, End-Stage | NA | Status: COMPLETED